about
The genome of the sparganosis tapeworm Spirometra erinaceieuropaei isolated from the biopsy of a migrating brain lesionThe genome of the hydatid tapeworm Echinococcus granulosusFood-borne trematodiasesCollection of Clonorchis sinensis adult worms from infected humans after praziquantel treatmentTRP channels in schistosomesEvidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoniCrystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of SchistosomiasisUniversal Stress Proteins as New Targets for Environmental and Therapeutic Interventions of SchistosomiasisGenetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoniInhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to PraziquantelThe ß subunit of voltage-gated Ca2+ channelsPraziquantel affects the regulatory myosin light chain of Schistosoma mansoni.Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel.Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.Towards an understanding of the mechanism of action of praziquantel.Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantelCestode genomics - progress and prospects for advancing basic and applied aspects of flatworm biology.Identification of intracellular and plasma membrane calcium channel homologues in pathogenic parasites.Schistosomiasis chemotherapy.Schistosome ABC multidrug transporters: From pharmacology to physiology.Ion channels and drug transporters as targets for anthelmintics.Pharmacology and potential physiological significance of schistosome multidrug resistance transportersStructure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action.Resistance as a tool for discovering and understanding targets in parasite neuromusculature.Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro.Pipeline for the identification and classification of ion channels in parasitic flatwormsThe schistosome in the mammalian host: understanding the mechanisms of adaptation.Inferences on the biochemical and environmental regulation of universal stress proteins from Schistosomiasis parasitesMCR synthesis of praziquantel derivativesABC multidrug transporters in schistosomes and other parasitic flatwormsCombination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.New approaches for understanding mechanisms of drug resistance in schistosomesSchistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibilityStructure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass SpectrometryIon channels and receptor as targets for the control of parasitic nematodes.Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms
P2860
Q21146634-8ECB54E7-BFDC-4961-A972-998E974FC3D7Q22122073-422CC5FA-B174-4E8F-8F59-0FE846084832Q24650873-C2393D19-74C2-498C-9CC0-F4F63FAA0FEFQ24656533-2C4810F6-0B0B-44FB-B6E4-68378C424FA4Q26738732-062046B6-6BF5-4D90-953F-E181B3D2CF47Q27303844-7FD64625-3564-4831-90B2-4F996FF45A09Q27684629-8B6AC3B4-46AC-429F-BA8D-2698ABD28610Q28065987-4D4EB629-8B1F-4BB9-B244-7E8AE72B5E9AQ28478288-F9E60599-6432-410F-BF63-EE692F5017EAQ28543846-19546B69-F9DD-4315-A1B5-CE903CC13F7BQ30155988-CFC61706-8AB8-4A77-A2AD-70A0D062A7EEQ33395216-9448E4F2-69D1-47C9-9DC4-F28E7678FEF5Q33552868-0B312108-6F90-4B8C-A1A8-A66384AB8345Q33747366-F6FECFF0-CB75-4908-8932-3EFE57908070Q33805145-62BFC355-DC53-4B54-B8EE-CC0035A7B9B2Q33914691-6B2C4611-404C-4FEF-9749-CF3E985D821FQ33960332-9EEAAF44-48AB-41BA-A481-08D1B40111E4Q33972939-46838AE5-3994-419C-B477-263B50B8C7EEQ34056171-95C9AAAA-854F-4E75-8D7B-36BE2398B429Q34354490-A61B5FC9-071A-40A4-A7D1-13FCB552802FQ34705514-19C308AC-9434-49DB-B41C-348925984214Q34782668-635ECEBD-29B9-40D9-B070-0D704724E462Q35159499-363B298D-1AC3-4C1A-800E-A010368B0FA4Q35223902-97A467A4-A6E9-4510-B456-3699B9810CAAQ36424568-6B21B4A5-2B67-4C14-A3EE-55C6109E2BB4Q36434061-78EB8812-C49D-4A2B-B71A-83217D5BBDC8Q36441487-D775CFA9-808C-48E8-BA1F-3010697D7443Q36442593-AEC92434-FE65-405B-8C12-2F724C6A1451Q36694802-A68EAB7B-077F-4F77-B20C-2867ACE94DD9Q36850831-9B117756-CF7E-4F39-A9D6-355F004C861DQ36851347-D28AC01C-FE89-4E50-B963-9879F35EE96FQ37017439-B04CC1DD-3C46-456E-9AAE-A35EE101590CQ37053762-D00C4471-F090-45D7-8D94-2A8531FE1E4EQ37152564-A3622058-6B87-4F7F-8DBE-BBC396F3B496Q37177725-9EC06108-42AC-4E3F-B2F9-4E8F60A7DEE8Q37223703-6B6EB79C-284C-4393-988B-D6DC83BC896EQ37409571-001A68F3-32A3-4613-B1D2-D63ACA3E0C50Q37428688-79A8BD76-5EE5-4EF3-8A8A-74B85D98B8A3Q37501925-FD02D533-EB75-49D2-985C-F2D5E8FDBF32Q37674908-E2B19205-D621-479C-BF7A-A706449EA7B2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Are Ca2+ channels targets of praziquantel action?
@ast
Are Ca2+ channels targets of praziquantel action?
@en
type
label
Are Ca2+ channels targets of praziquantel action?
@ast
Are Ca2+ channels targets of praziquantel action?
@en
prefLabel
Are Ca2+ channels targets of praziquantel action?
@ast
Are Ca2+ channels targets of praziquantel action?
@en
P1476
Are Ca2+ channels targets of praziquantel action?
@en
P2093
Robert M Greenberg
P356
10.1016/J.IJPARA.2004.09.004
P577
2004-10-21T00:00:00Z